Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$554M |
| 2 |
Chevron
CVX
|
+$299M |
| 3 |
Visa
V
|
+$286M |
| 4 |
JPMorgan Chase
JPM
|
+$285M |
| 5 |
ExxonMobil
XOM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$459M |
| 2 |
Apple
AAPL
|
+$345M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$243M |
| 4 |
AbbVie
ABBV
|
+$222M |
| 5 |
Cisco
CSCO
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.59% |
| 2 | Healthcare | 12.96% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Communication Services | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
The Bancorp
TBBK
$2.9B
| $877K | ﹤0.01% |
42,328
-3,126
| -7% | -$60.8K |
|
|
LADR
2627
Ladder Capital
LADR
$1.24B
| $876K | ﹤0.01% |
74,280
-6,447
| -8% | -$70.2K |
|
|
AKRO
2628
DELISTED
Akero Therapeutics
AKRO
| $874K | ﹤0.01% |
30,129
-35,926
| -54% | -$1.09M |
|
2629
Xerox
XRX
$425M
| $873K | ﹤0.01% |
35,954
-250,648
| -87% | -$5.99M |
|
2630
Neuronetics
STIM
$166M
| $872K | ﹤0.01% |
70,544
+67,144
| +1,975% | +$1.03M |
|
2631
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
| $871K | ﹤0.01% |
21,137
+13,481
| +176% | +$555K |
|
2632
VanEck Gold Miners ETF
GDX
$27.4B
| $870K | ﹤0.01% |
26,750
-689
| -3% | -$23.5K |
|
2633
Ocular Therapeutix
OCUL
$2.02B
| $868K | ﹤0.01% |
52,922
-8,375
| -14% | -$161K |
|
2634
Griffon
GFF
$4.86B
| $867K | ﹤0.01% |
31,941
-101,612
| -76% | -$2.51M |
|
|
PFC
2635
DELISTED
Premier Financial Corp. Common Stock
PFC
| $863K | ﹤0.01% |
25,968
-4,823
| -16% | -$143K |
|
2636
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
| $862K | ﹤0.01% |
7,874
-6,299
| -44% | -$701K |
|
|
CRHC
2637
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $858K | ﹤0.01% |
+87,300
| New | +$920K |
|
2638
ALX Oncology
ALXO
$283M
| $855K | ﹤0.01% |
11,608
+4,476
| +63% | +$352K |
|
2639
FLEX LNG
FLNG
$1.67B
| $855K | ﹤0.01% |
95,689
-107,803
| -53% | -$958K |
|
2640
TriCo Bancshares
TCBK
$1.83B
| $854K | ﹤0.01% |
18,034
-1,614
| -8% | -$69.6K |
|
2641
iShares US Financials ETF
IYF
$4.61B
| $851K | ﹤0.01% |
11,360
| – | – |
|
2642
Vertiv
VRT
$105B
| $850K | ﹤0.01% |
42,474
-172,637
| -80% | -$3.49M |
|
2643
Saic
SAIC
$5.35B
| $849K | ﹤0.01% |
10,159
-13,642
| -57% | -$1.28M |
|
2644
Team
TISI
$77.7M
| $848K | ﹤0.01% |
7,355
-489
| -6% | -$53.6K |
|
|
SHYF
2645
DELISTED
The Shyft Group
SHYF
| $847K | ﹤0.01% |
22,752
-3,065
| -12% | -$103K |
|
2646
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $847K | ﹤0.01% |
10,230
| – | – |
|
|
AEF
2647
abrdn Emerging Markets Equity Income Fund
AEF
$367M
| $846K | ﹤0.01% |
97,721
| – | – |
|
|
KNTE
2648
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $845K | ﹤0.01% |
+27,127
| New | +$945K |
|
|
AAN
2649
DELISTED
The Aaron's Company Inc
AAN
| $844K | ﹤0.01% |
32,877
-2,046
| -6% | -$44.8K |
|
|
FPRX
2650
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $844K | ﹤0.01% |
22,408
-6,987
| -24% | -$174K |
|
Similar funds
Deutsche Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Deutsche Bank held 4,832 positions worth $186B, up 13% from $164B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Deutsche Bank deployed $12.1B of net new capital in Q1 2021, opening 392 new positions and adding to 1,770 existing holdings. Its largest new stake was Ferguson: 746,157 shares worth $89.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Verizon, an estimated $459M trimmed.
- Deutsche Bank's largest Q1 2021 buy was Ferguson: 746,157 shares worth $89.6M.
- Deutsche Bank added most to Microsoft in Q1 2021, an estimated $554M increase.
- Deutsche Bank's biggest Q1 2021 reduction was Verizon, cutting an estimated $459M.
- Deutsche Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $41.2M.
- Deutsche Bank's ten largest holdings make up 19% of its $186B portfolio in Q1 2021.
- Deutsche Bank opened 392 new positions and closed 267 in Q1 2021.
- Deutsche Bank's portfolio value rose 13% quarter-over-quarter to $186B.
Based on Deutsche Bank's 13F filing for Q1 2021, filed 13 May 2021.